Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 2
2013 1
2015 1
2016 1
2017 3
2018 2
2019 5
2020 1
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Impact of proton therapy on antitumor immune response.
Mirjolet C, Nicol A, Limagne E, Mura C, Richard C, Morgand V, Rousseau M, Boidot R, Ghiringhelli F, Noel G, Burckel H. Mirjolet C, et al. Sci Rep. 2021 Jun 29;11(1):13444. doi: 10.1038/s41598-021-92942-1. Sci Rep. 2021. PMID: 34188135 Free PMC article.
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.
Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin G, Foray N, Pereira S. Deneuve S, et al. Among authors: mirjolet c. Cancers (Basel). 2021 May 19;13(10):2477. doi: 10.3390/cancers13102477. Cancers (Basel). 2021. PMID: 34069662 Free PMC article.
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.
Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, Marguier A, Tochet F, Dosset M, Boustani J, Ravel P, Boidot R, Spehner L, Haicheur-Adjouri N, Marliot F, Pallandre JR, Bonnefoy F, Scripcariu V, Van den Eynde M, Cornillot E, Mirjolet C, Pages F, Adotevi O. Lauret Marie Joseph E, et al. Among authors: mirjolet c. J Immunother Cancer. 2021 Jul;9(7):e002256. doi: 10.1136/jitc-2020-002256. J Immunother Cancer. 2021. PMID: 34230108 Free PMC article.
25 results